• Subscribe for Free (RSS + E-mail)
    RSS + E-mail

    Boston Angel Investors →

    Featured▾

    • Napa Summit 2013 →

  • Xconomy Boston

  • Xperience
    Tech + Life▾
      • Nine Lessons for Innovators from a Nobel Prize-Winning Psychologist
        Nine Lessons for Innovators from a Nobel Prize-Winning Psychologist
      • Life After PowerPoint: Prezi Zooms Ahead in Digital Storytelling
        Life After PowerPoint: Prezi Zooms Ahead in Digital Storytelling
      • Online Galleries Help Shoppers Get Smart About Art
        Online Galleries Help Shoppers Get Smart About Art
      • Do You Need an Extended Warranty? Do the Math, Says SquareTrade
        Do You Need an Extended Warranty? Do the Math, Says SquareTrade
      • LG Parties with Optimus G Pro, Pulls a Note or II from Samsung
        LG Parties with Optimus G Pro, Pulls a Note or II from Samsung
      View More in Xperience ›
  • Our
    Cities▾
    • Boston›
      • Twitter Shows Off Bluefin Labs Buy with New TV Ad Targeting
        Twitter Shows Off Bluefin Labs Buy with New TV Ad Targeting
      View More in Boston ›
    • Boulder/Denver›
      • Scheduling App Maker TeamSnap Grabs Rival Weplay’s Users, Content
        Scheduling App Maker TeamSnap Grabs Rival Weplay’s Users, Content
      View More in Boulder/Denver ›
    • Detroit›
      • Girl Develop It’s Detroit Chapter Teaches Women to Code
        Girl Develop It’s Detroit Chapter Teaches Women to Code
      View More in Detroit ›
    • New York›
      • Shutterstock CEO Jon Oringer Speaks About Deciding to Go Public
        Shutterstock CEO Jon Oringer Speaks About Deciding to Go Public
      View More in New York ›
    • San Diego›
      • San Diego Life Sciences Roundup: Effector, Ignyta, and More
        San Diego Life Sciences Roundup: Effector, Ignyta, and More
      View More in San Diego ›
    • San Francisco›
      • Twitter Shows Off Bluefin Labs Buy with New TV Ad Targeting
        Twitter Shows Off Bluefin Labs Buy with New TV Ad Targeting
      View More in San Francisco ›
    • Seattle›
      • Cardeas Pharma Snags $34M For Antibiotic Against Hospital Infections
        Cardeas Pharma Snags $34M For Antibiotic Against Hospital Infections
      View More in Seattle ›
    • Texas›
      • Under Purple Spotlights, Surge Accelerator’s Startups Make Their Debut
        Under Purple Spotlights, Surge Accelerator’s Startups Make Their Debut
      View More in Texas ›
  • Tech
    Channels ▾
    • Cleantech›
      • Student Teams Working on Environmental Innovation Inspire
        Student Teams Working on Environmental Innovation Inspire
      View More in Cleantech ›
    • Health IT›
      • Blueprint Health Demo Day Reveals Ideas for Hospital Efficiency
        Blueprint Health Demo Day Reveals Ideas for Hospital Efficiency
      View More in Health IT ›
    • Life Sciences›
      • San Diego Life Sciences Roundup: Qualcomm, Amylin, Organovo & More
        San Diego Life Sciences Roundup: Qualcomm, Amylin, Organovo & More
      View More in Life Sciences ›
    • Mobile›
      • Stealthy No More, Skillz Brings Cash Tournaments to Mobile Games
        Stealthy No More, Skillz Brings Cash Tournaments to Mobile Games
      View More in Mobile ›
    • Startups›
      • PowerClip Charges up NY Tech Meetup with an Idea for Emergencies
        PowerClip Charges up NY Tech Meetup with an Idea for Emergencies
      View More in Startups ›
  • Meet the
    Xconomists ▾
    • jbaptiste

      Jason Baptiste

      CEO and Co-Founder of OnSwipe

    • JPanetta

      Joe Panetta

      President and CEO, Biocom

    • lrhoads

      Linden Rhoads

      Vice Provost, TechTransfer, University of Washington

    • edyson

      Esther Dyson

      Chairman, EDventure Holdings

    • Meet All the Xconomists ›
    • pthompson

      Peter Thompson

      Venture Partner, OrbiMed Advisors

    • jabele

      John Abele

      Co-Founder and Director, Boston Scientific Corporation

    • kshokat

      Kevan Shokat

      Chair, Dept. of Cellular and Molecular Pharmacology, UCSF

    • bfrei

      Brent Frei

      Co-Founder and Executive Chairman, Smartsheet.com

  • Our
    Events ▾
    • The Napa Summit 2013: New Rules for Growth

      6/3/13 · San Francisco

      The Napa Summit 2013: New Rules for Growth
    • XSITE 2013: Boston’s Tech Revival

      6/19/13 · Boston

      XSITE 2013: Boston’s Tech Revival
    • View All Xconomy Events › Boston Events ›
    • Boulder/Denver Events › Detroit Events ›
    • New York Events › San Diego Events ›
    • San Francisco Events › Seattle Events ›
    • Texas Events ›
  • Boston Home
  • Boston Events
  • Local Jobs
  • Archives
  • Xconomists
  • X Lists
  • VC / M&A Deals

From Bluebird Bio, Third Rock & Genzyme’s Gene Therapy Bet, Shows Promise for Blood Disorder:

blubird
blubird—

Bluebird Bio

Underwriters and Partners

Xconomy Events Across the Network

The Napa Summit 2013: New Rules for Growth

San Francisco · 6/3/13

More Xconomy Events

Connect with Xconomy

  • Xconomy on Facebook
  • Xconomy on Twitter
  • Xconomy on Linkedin
  • Xconomy on Google PLus
  • Xconomy Feeds

Xconomy’s Most Popular

  1. Henri Termeer on Startups, Drug Prices, Getting Older (Part 1)
  2. Nine Lessons for Innovators from a Nobel Prize-Winning Psychologist
  3. Xconomy Opens in Texas, Expanding Roundup of Innovation Across U.S.
  4. Life After PowerPoint: Prezi Zooms Ahead in Digital Storytelling
  5. Announcing Xconomy Napa Summit 2013: New Rules for Growth

Xconomy on Demand

Did you miss something? Don't despair…

Xconomy offers a number of ways to subscribe for free!

Subscribe Now
IDG Tech Network
Protected by Mozy
Eventbrite - events made easy
  • Home
  • Privacy/DMCA
  • About
  • Contact Us
  • Archives
  • Advertise
  • Subscribe for Free

Business, life sciences, and technology news — covering Boston, Seattle, San Diego, Detroit, San Francisco, New York, Boulder/Denver, Texas and beyond.

© 2007-2013, Xconomy, Inc. Xconomy is a registered service mark of Xconomy, Inc. All rights reserved.

Website development support from Andrew Koyfman with design support from Rob Hunter.